论文部分内容阅读
Poly (ADP-ribose) polymerase-1 (PARP-1) serves as a critical enzyme in the repair of single-strand DNA breaks.PARP inhibitors (PARPi) can sensitize tumors to DNA-damaging agents and to selectively kill homologous recombination (HR)-deficient tumor cells, such those involving BRCA1/2 mutations.However, PARPi resistance frequently occurs, and therefore additional strategies that synergize with PARPi to enhance anti-tumor activity are necessary.